Moderna Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Moderna Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Moderna Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Moderna Inc. is MRNA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Moderna Inc. has its primary listing on NASDAQ. You can trade Moderna Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Moderna Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Moderna Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Moderna Inc..